|
1
|
Schutte K, Bornschein J and Malfertheiner
P: Hepatocellular carcinoma - epidemiological trends and risk
factors. Dig Dis. 27:80–92. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Butterfield LH: Recent advances in
immunotherapy for hepatocellular cancer. Swiss Med Wkly. 137:83–90.
2007.PubMed/NCBI
|
|
3
|
Breous E and Thimme R: Potential of
immunotherapy for hepatocellular carcinoma. J Hepatol. 54:830–834.
2011. View Article : Google Scholar
|
|
4
|
Liu Y, Daley S, Evdokimova VN, Zdobinski
DD, Potter DM and Butterfield LH: Hierarchy of alpha fetoprotein
(AFP)-specific T cell responses in subjects with AFP-positive
hepatocellular cancer. J Immunol. 177:712–721. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Komori H, Nakatsura T, Senju S, Yoshitake
Y, Motomura Y, Ikuta Y, Fukuma D, Yokomine K, Harao M, Beppu T, et
al: Identification of HLA-A2- or HLA-A24-restricted CTL epitopes
possibly useful for glypican-3-specific immunotherapy of
hepatocellular carcinoma. Clin Cancer Res. 12:2689–2697. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gehring AJ, Ho ZZ, Tan AT, Aung MO, Lee
KH, Tan KC, Lim SG and Bertoletti A: Profile of tumor
antigen-specific CD8 T cells in patients with hepatitis B
virus-related hepatocellular carcinoma. Gastroenterology.
137:682–690. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bricard G, Bouzourene H, Martinet O,
Rimoldi D, Halkic N, Gillet M, Chaubert P, Macdonald HR, Romero P,
Cerottini JC and Speiser DE: Naturally acquired MAGE-A10- and
SSX-2-specific CD8+ T cell responses in patients with
hepatocellular carcinoma. J Immunol. 174:1709–1716. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zerbini A, Pilli M, Soliani P, Ziegler S,
Pelosi G, Orlandini A, Cavallo C, Uggeri J, Scandroglio R, Crafa P,
et al: Ex vivo characterization of tumor-derived melanoma antigen
encoding gene-specific CD8+ cells in patients with
hepatocellular carcinoma. J Hepatol. 40:102–109. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mizukoshi E, Nakamoto Y, Marukawa Y, Arai
K, Yamashita T, Tsuji H, Kuzushima K, Takiguchi M and Kaneko S:
Cytotoxic T cell responses to human telomerase reverse
transcriptase in patients with hepatocellular carcinoma.
Hepatology. 43:1284–1294. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Butterfield LH, Ribas A, Dissette VB, Lee
Y, Yang JQ, De la Rocha P, Duran SD, Hernandez J, Seja E, Potter
DM, et al: A phase I/II trial testing immunization of
hepatocellular carcinoma patients with dendritic cells pulsed with
four alpha-fetoprotein peptides. Clin Cancer Res. 12:2817–2825.
2006. View Article : Google Scholar
|
|
11
|
Thimme R, Neagu M, Boettler T,
Neumann-Haefelin C, Kersting N, Geissler M, Makowiec F, Obermaier
R, Hopt UT, Blum HE and Spangenberg HC: Comprehensive analysis of
the alpha-fetoprotein-specific CD8+ T cell responses in
patients with hepatocellular carcinoma. Hepatology. 48:1821–1833.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gaugler B, Van den Eynde B, van der
Bruggen P, Romero P, Gaforio JJ, De Plaen E, Lethe B, Brasseur F
and Boon T: Human gene MAGE-3 codes for an antigen recognized on a
melanoma by autologous cytolytic T lymphocytes. J Exp Med.
179:921–930. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
van der Bruggen P, Traversari C, Chomez P,
Lurquin C, De Plaen E, Van den Eynde B, Knuth A and Boon T: A gene
encoding an antigen recognized by cytolytic T lymphocytes on a
human melanoma. Science. 254:1643–1647. 1991.
|
|
14
|
Pascolo S, Schirle M, Guckel B, Dumrese T,
Stumm S, Kayser S, Moris A, Wallwiener D, Rammensee HG and
Stevanovic S: A MAGE-A1 HLA-A A*0201 epitope identified by mass
spectrometry. Cancer Res. 61:4072–4077. 2001.
|
|
15
|
Sahin U, Tureci O, Schmitt H, Cochlovius
B, Johannes T, Schmits R, Stenner F, Luo G, Schobert I and
Pfreundschuh M: Human neoplasms elicit multiple specific immune
responses in the autologous host. Proc Natl Acad Sci USA.
92:11810–11813. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gure AO, Stockert E, Scanlan MJ, Keresztes
RS, Jager D, Altorki NK, Old LJ and Chen YT: Serological
identification of embryonic neural proteins as highly immunogenic
tumor antigens in small cell lung cancer. Proc Natl Acad Sci USA.
97:4198–4203. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Scanlan MJ, Gure AO, Jungbluth AA, Old LJ
and Chen YT: Cancer/testis antigens: an expanding family of targets
for cancer immunotherapy. Immunol Rev. 188:22–32. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Caballero OL and Chen YT: Cancer/testis
(CT) antigens: potential targets for immunotherapy. Cancer Sci.
100:2014–2021. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Simpson AJ, Caballero OL, Jungbluth A,
Chen YT and Old LJ: Cancer/testis antigens, gametogenesis and
cancer. Nat Rev Cancer. 5:615–625. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kim YD, Park HR, Song MH, Shin DH, Lee CH,
Lee MK and Lee SY: Pattern of cancer/testis antigen expression in
lung cancer patients. Int J Mol Med. 29:656–662. 2012.PubMed/NCBI
|
|
21
|
Chen YT, Gure AO, Tsang S, Stockert E,
Jager E, Knuth A and Old LJ: Identification of multiple
cancer/testis antigens by allogeneic antibody screening of a
melanoma cell line library. Proc Natl Acad Sci USA. 95:6919–6923.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen YT, Scanlan MJ, Sahin U, Tureci O,
Gure AO, Tsang S, Williamson B, Stockert E, Pfreundschuh M and Old
LJ: A testicular antigen aberrantly expressed in human cancers
detected by autologous antibody screening. Proc Natl Acad Sci USA.
94:1914–1918. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tureci O, Sahin U, Schobert I, Koslowski
M, Scmitt H, Schild HJ, Stenner F, Seitz G, Rammensee HG and
Pfreundschuh M: The SSX-2 gene, which is involved in the t(X;18)
translocation of synovial sarcomas, codes for the human tumor
antigen HOM-MEL-40. Cancer Res. 56:4766–4772. 1996.PubMed/NCBI
|
|
24
|
Tureci O, Sahin U, Zwick C, Koslowski M,
Seitz G and Pfreundschuh M: Identification of a meiosis-specific
protein as a member of the class of cancer/testis antigens. Proc
Natl Acad Sci USA. 95:5211–5216. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lee SY, Obata Y, Yoshida M, Stockert E,
Williamson B, Jungbluth AA, Chen YT, Old LJ and Scanlan MJ:
Immunomic analysis of human sarcoma. Proc Natl Acad Sci USA.
100:2651–2656. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lee SY, Williamson B, Caballero OL, Chen
YT, Scanlan MJ, Ritter G, Jongeneel CV, Simpson AJ and Old LJ:
Identification of the gonad-specific anion transporter SLCO6A1 as a
cancer/testis (CT) antigen expressed in human lung cancer. Cancer
Immun. 4:132004.PubMed/NCBI
|
|
27
|
Song MH, Ha JC, Lee SM, Park YM and Lee
SY: Identification of BCP-20 (FBXO39) as a cancer/testis antigen
from colon cancer patients by SEREX. Biochem Biophys Res Commun.
408:195–201. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hasegawa K, Ono T, Matsushita H, Shimono
M, Noguchi Y, Mizutani Y, Kodama J, Kudo T and Nakayama E: A-kinase
anchoring protein 3 messenger RNA expression in ovarian cancer and
its implication on prognosis. Int J Cancer. 108:86–90. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zendman AJ, Cornelissen IM, Weidle UH,
Ruiter DJ and van Muijen GN: CTp11, a novel member of the family of
human cancer/testis antigens. Cancer Res. 59:6223–6229.
1999.PubMed/NCBI
|
|
30
|
Conklin D, Holderman S, Whitmore TE,
Maurer M and Feldhaus AL: Molecular cloning, chromosome mapping and
characterization of UBQLN3 a testis-specific gene that contains a
ubiquitin-like domain. Gene. 249:91–98. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhao L, Mou DC, Peng JR, Huang L, Wu ZA
and Leng XS: Diagnostic value of cancer-testis antigen mRNA in
peripheral blood from hepatocellular carcinoma patients. World J
Gastroenterol. 16:4072–4078. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Vijayaraghavan S, Liberty GA, Mohan J,
Winfrey VP, Olson GE and Carr DW: Isolation and molecular
characterization of AKAP110, a novel, sperm-specific protein kinase
A-anchoring protein. Mol Endocrinol. 13:705–717. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Carnegie GK, Means CK and Scott JD:
A-kinase anchoring proteins: from protein complexes to physiology
and disease. IUBMB Life. 61:394–406. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sharma S, Qian F, Keitz B, Driscoll D,
Scanlan MJ, Skipper J, Rodabaugh K, Lele S, Old LJ and Odunsi K:
A-kinase anchoring protein 3 messenger RNA expression correlates
with poor prognosis in epithelial ovarian cancer. Gynecol Oncol.
99:183–188. 2005. View Article : Google Scholar : PubMed/NCBI
|
